Department of Surgery.
Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland.
Clin J Am Soc Nephrol. 2019 Apr 5;14(4):576-582. doi: 10.2215/CJN.12921118. Epub 2019 Mar 19.
Frailty, a syndrome distinct from comorbidity and disability, is clinically manifested as a decreased resistance to stressors and is present in up to 35% of patient with ESKD. It is associated with falls, hospitalizations, poor cognitive function, and mortality. Also, frailty is associated with poor outcomes after kidney transplant, including delirium and mortality. Frailty is likely also associated with decreased access to kidney transplantation, given its association with poor outcomes on dialysis and post-transplant. Yet, clinicians have difficulty identifying which patients are frail; therefore, we sought to quantify if frail kidney transplant candidates had similar access to kidney transplantation as nonfrail candidates.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We studied 7078 kidney transplant candidates (2009-2018) in a three-center prospective cohort study of frailty. Fried frailty (unintentional weight loss, grip strength, walking speed, exhaustion, and activity level) was measured at outpatient kidney transplant evaluation. We estimated time to listing and transplant rate by frailty status using Cox proportional hazards and Poisson regression, adjusting for demographic and health factors.
The mean age was 54 years (SD 13; range, 18-89), 40% were women, 34% were black, and 21% were frail. Frail participants were almost half as likely to be listed for kidney transplantation (hazard ratio, 0.62; 95% confidence interval, 0.56 to 0.69; <0.001) compared with nonfrail participants, independent of age and other demographic factors. Furthermore, frail candidates were transplanted 32% less frequently than nonfrail candidates (incidence rate ratio, 0.68; 95% confidence interval, 0.58 to 0.81; <0.001).
Frailty is associated with lower chance of listing and lower rate of transplant, and is a potentially modifiable risk factor.
衰弱是一种与共病和残疾不同的综合征,其临床表现为对压力源的抵抗力下降,在多达 35%的终末期肾病(ESKD)患者中存在。它与跌倒、住院、认知功能差和死亡率有关。此外,衰弱与肾移植后的不良结局有关,包括谵妄和死亡率。由于衰弱与透析和移植后不良结局相关,因此它可能与获得肾移植的机会减少有关。然而,临床医生难以识别哪些患者衰弱,因此,我们试图量化虚弱的肾移植候选者与非虚弱候选者获得肾移植的机会是否相似。
设计、地点、参与者和测量:我们对 7078 名肾移植候选者(2009-2018 年)进行了一项前瞻性队列研究,该研究在三个中心进行,研究内容为衰弱。在门诊肾移植评估时测量了 Fried 衰弱(非故意体重减轻、握力、步行速度、疲劳和活动水平)。我们根据衰弱状况,使用 Cox 比例风险和泊松回归估计了列入名单和移植的时间,调整了人口统计学和健康因素。
平均年龄为 54 岁(标准差 13;范围 18-89),40%为女性,34%为黑人,21%为衰弱。与非衰弱参与者相比,衰弱参与者被列入肾移植名单的可能性几乎减半(风险比,0.62;95%置信区间,0.56 至 0.69;<0.001),独立于年龄和其他人口统计学因素。此外,与非衰弱候选者相比,衰弱候选者的移植频率低 32%(发病率比,0.68;95%置信区间,0.58 至 0.81;<0.001)。
衰弱与列入名单的机会降低和移植率降低有关,是一个潜在可改变的危险因素。